European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.
With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with focus topics covering areas such as Biosimilars, Microbiology, Biomanufacturing, Peptides, plus special editions for the BIO-Europe events.
For further information please contact:
Advertising: Louise White
Editorial: Amber O’Rourke
Connect with us on Twitter: follow @EBRmagazine
